# A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

> **NCT02411955** · PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 1077 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Tazarotene Cream 0.1%
- **DRUG:** Tazorac®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02411955
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 1077 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411955, "A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02411955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*